The protein sequencing market has seen considerable growth due to a variety of factors.
• In recent times, the market size for protein sequencing has witnessed rapid expansion. The market is expected to rise from $1.7 billion in 2024 to $1.88 billion in 2025, indicating a compound annual growth rate (CAGR) of 10.5%.
The factors contributing to the growth during the historic period include demand in research, medical diagnostics, development in the pharmaceutical sector, applications in agriculture, forensic analysis, the discovery of biomarkers, and studies on genetic evolution.
The protein sequencing market is expected to maintain its strong growth trajectory in upcoming years.
• In the coming years, the protein sequencing market is anticipated to experience rapid expansion. The market is projected to reach $2.76 billion in 2029, with a compound annual growth rate (CAGR) of 10.1%.
This growth during the forecast period is linked to the integration of clinical genomics, the expansion of agricultural genomics, drug safety, and pharmacogenomics, in addition to prenatal and newborn screening, as well as environmental DNA analysis. The forecast period will also see key trends such as an increased demand for next-generation sequencing, a rise in applications in clinical diagnostics, and enhanced investments in genomics research, along with a broader application in personalized medicine.
The protein sequencing market's growth is predicted to be propelled by the increasing prevalence of genetic diseases. Genetic diseases refer to any disease or disorder induced by abnormalities or mutations in a person's genetic material, typically their DNA. The increasing incidence of genetic diseases is due to spontaneous or inherited genetic mutations. Protein sequencing can facilitate the identification of genetic variants that cause diseases, thereby aiding in the detection of protein biomarkers that indicate a given disease state or physiological condition. For example, the United States National Library of Medicine, a U.S. medical library, reported that the total number of new genetic tests in the United States grew from around 1,000 in 2021 to approximately 3,000 tests in 2022, as recorded in April 2023. Hence, the increasing prevalence of genetic diseases is fueling the expansion of the protein sequencing market.
The protein sequencing market covered in this report is segmented –
1) By Product And Service: Protein Sequencing Products, Protein Sequencing Services
2) By Application: Bio-Therapeutics, Genetic Engineering, Other Applications
3) By End User 3: Pharmaceutical And Biotechnology Companies, Other End-Users
Subsegments:
1) By Protein Sequencing Products: Sequencing Kits, Reagents, Instruments, Consumables
2) By Protein Sequencing Services: Custom Protein Sequencing, Analytical Protein Sequencing, Bioinformatics Services, Proteomics Services
Leading firms in the protein sequencing sector are innovating and introducing technologically advanced products such as upgraded sequencing kits in order to achieve a competitive advantage. Sequencing kits comprise essentials like reagents, chemicals, and materials needed for the preparation of samples and conducting sequencing experiments. For example, Quantum-Si, an American protein sequencing corporation, unveiled its Protein Sequencing Kit V2 in February 2024. This kit serves as an enhancement to their Platinum protein sequencing platform and provides improved sequencing performance through assay improvements and the introduction of a novel amino acid recognizer. It also facilitates the identification of unexplored proteins via advanced analysis and inference tools. These enhancements result in improved sequencing performance, the capacity to identify unknown proteins, high reproduction consistency, and a reduction in cost per amino acid by three times.
Major companies operating in the protein sequencing market are:
• F Hoffmann-La Roche Ltd.
• Thermo Fisher Scientific Inc.
• Merck KGaA
• Eurofins Scientific SE
• Illumina Inc.
• Beckman Coulter Inc.
• PerkinElmer Inc.
• BGI Group
• LGC Limited
• GenScript Biotech Corporation
• Oxford Nanopore Technologies Ltd.
• Pacific Biosciences of California Inc.
• Macrogen Inc.
• GENEWIZ Inc.
• Quintara Biosciences Inc.
• Source BioScience plc
• Microsynth AG
• Fasteris SA
• GenHunter Corporation
• Nucleics Pty Ltd.
• SciGenom Labs Pvt Ltd.
• StarSEQ GmbH
• GATC Biotech AG
• Agilent Technologies Inc.
• CeMIA SA
North America was the largest region in the protein sequencing market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the protein sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.